Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial
尼拉帕尼和醋酸阿比特龙联合泼尼松治疗HRR缺陷型转移性去势敏感性前列腺癌：一项随机3期试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03961-8
Attard, Gerhardt; Agarwal, Neeraj; Graff, Julie N; Sandhu, Shahneen; Efstathiou, Eleni; Özgüroğlu, Mustafa; Pereira de Santana Gomes, Andrea J; Vianna, Karina; Luo, Hong; Gotto, Geoffrey T; Cheng, Heather H; Kim, Won; Varela, Carly R; Schaeffer, Daneen; Kramer, Kassie; Li, Susan; Baron, Benoit; Shen, Fei; Mundle, Suneel D; McCarthy, Sharon A; Olmos, David; Chi, Kim N; Rathkopf, Dana E
